Agreement signedPublished 18 Apr 2022
Fulgent Genetics, Inc. /
Inform Diagnostics
Fulgent Genetics, Inc. agrees to buy Inform Diagnostics
- Price
- $170m
- Stage
- Agreement signed
01 / BuyerFulgent Genetics, Inc.
02 / TargetInform Diagnostics
What happened
Fulgent Genetics, Inc. agreed to acquire Inform Diagnostics for approximately $170 million, according to a filing dated April 18, 2022.
The source
Everything on this page comes from the source below.
01
Source · Source
Fulgent Genetics, Inc. agrees to buy Inform Diagnostics
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Announced
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly